Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03085953 · ClinicalTrials.gov registry record · NA
Study for the Employment Retention of Veterans
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 511
- Enrollment target
NCT03085953: Completed NA study, sponsored by Oregon Health and Science University.
NCT03085953 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 511 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03085953, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 511 participants
- Enrollment target
Study Summary
The Study for Employment Retention of Veterans (SERVe) is a randomized controlled trial, available exclusively to Oregon employers of veterans. It is designed to develop and scientifically evaluate Veteran-supportive supervisor training (VSST) that may enhance retention of veterans, with the goal of improving workplace culture and general well-being to our service members. The intervention, applied to workplace supervisors, will be measured by experience of veterans, assessing workplace experiences, health, well-being, as well as employees' spouse/partners' family experiences, health and well-being, and workplace outcomes.
Primary Outcome
VSSB as measured by Perry et al.'s (2017) scale, as impacted by the Veteran Supportive Supervisor Training
Interventions
- OTHER Waitlist Control
- BEHAVIORAL Veteran Supportive Supervisor Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2013-04 |
| Est. Completion | 2019-02-07 |
| Phase | NA |
What the finished NCT03085953 record still lists
NCT03085953 is an interventional study that assigns participants to a tested intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Waitlist Control is the first listed.
NCT03085953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03085953 about?
NCT03085953 is a clinical study titled "Study for the Employment Retention of Veterans". The Study for Employment Retention of Veterans (SERVe) is a randomized controlled trial, available exclusively to Oregon employers of veterans. It is designed to develop and scientifically evaluate Veteran-supportive supervisor training (VSST) that may enhance retention of veterans, with the goal of...
What is the current status of trial NCT03085953?
This trial is currently completed. It is a NA study. The enrollment target is 511 participants. The study started on 2013-04. Estimated completion is 2019-02-07.
What interventions are being tested in trial NCT03085953?
The interventions under investigation include: Waitlist Control (OTHER), Veteran Supportive Supervisor Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03085953?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03085953's enrollment target sits among peer trials
511 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia